Liminatus Pharma Class A (LIMN)

Profile

Full Name

Liminatus Pharma, Inc.

Ticker Symbol

LIMN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 1, 2025

Indexes

Not included

Website

http://liminatuspharma.com

Employees

3

Key Details

Price

$8.81(-14.88%)

Market cap

$229.19M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.19(-70.16% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.81
    LIMN price is $8.81

    30-Day Relative Volume

    0.58
    LIMN 30-day relative volume is 0.58

    Price Performance

    Price Today change

    -14.88%
    LIMN price is down -14.88% today

    Price YTD change

    -
    LIMN price ytd change is unknown

    Price 1-year change

    -
    LIMN price 1-year change is unknown

    Price 3-year change

    -
    LIMN price 3-year change is unknown

    Price Range

    Price All-time high

    $33.66
    LIMN price is currently -73.83% below its historical high of $33.66

    Price 3-year low

    $4.40
    LIMN price is currently +100.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $229.19M
    LIMN market capitalization is $229.19 million

    Market cap 3-year change

    -
    LIMN market capitalization 3-year change is unknown

    Market cap All-time high

    $693.81M
    LIMN market capitalization is currently -66.97% below its historical high of $693.81 million

    Market cap sector rank

    55.4%
    LIMN market capitalization is higher than 55.4% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    LIMN shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    LIMN shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.42
    LIMN beta is -0.42

    200-day SMA

    $11.18
    LIMN price is currently -21.17% below its 200-day simple moving average

    50-day SMA

    $11.18
    LIMN price is currently -21.17% below its 50-day simple moving average

    RSI

    44.30
    LIMN 14-day relative strength index is 44.30

    Volume

    0.58
    LIMN 30-day relative volume is 0.58

    ATR

    $5.12
    LIMN average true range is $5.12

    10-day Historical Volatility

    417.83%
    LIMN 10-day historical volatility is 417.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    LIMN annual revenue value is unknown

    Revenue Analysts estimate

    -
    LIMN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    LIMN annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    LIMN annual revenue is unknown

    EPS

    EPS

    -$0.19
    LIMN annual earnings per share is -$0.19

    EPS Analysts estimate

    -
    LIMN annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -70.16%
    LIMN annual earnings per share is down -70.16% year-on-year

    EPS Sector rank

    76.28%
    LIMN annual earnings per share is higher than 76.28% of companies in Healthcare sector

    Profit

    Gross profit

    -
    LIMN annual gross profit value is unknown

    Gross margin

    -
    LIMN annual gross profit margin value is unknown

    Operating profit

    -$4.82M
    LIMN annual operating income is -$4.82 million

    Operating margin

    -
    LIMN annual operating profit margin value is unknown

    Net income

    -$4.98M
    LIMN annual net profit is -$4.98 million

    Net margin

    -
    LIMN annual net profit margin value is unknown

    Expenses

    Total expenses

    $4.82M
    LIMN annual total expenses is $4.82 million

    Operating expenses

    $4.82M
    LIMN annual total operating expenses is $4.82 million

    Cost of goods sold

    -
    LIMN annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $1.06M
    LIMN annual SGA is $1.06 million

    Depreciation and amortization

    -
    LIMN annual depreciation & amortization value is unknown

    Interest expense

    $175.00K
    LIMN annual interest expense is $175.00 thousand

    Income tax

    -
    LIMN annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$4.81M
    LIMN annual earnings before interest & taxes is -$4.81 million

    EBITDA

    -$4.81M
    LIMN annual EBITDA is -$4.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.24M
    LIMN annual total assets is $2.24 million

    Non current assets

    $1000.00
    LIMN annual long term assets is $1000.00

    Current assets

    $2.24M
    LIMN annual total current assets is $2.24 million

    Cash and cash equivalents

    $434.00K
    LIMN annual cash & cash equivalents is $434.00 thousand

    Accounts receivable

    -
    LIMN annual accounts receivable value is unknown

    Inventory

    -
    LIMN annual inventory value is unknown

    Liabilities

    Total liabilities

    $18.04M
    LIMN annual total liabilities is $18.04 million

    Long term liabilities

    $0.00
    LIMN annual total long term liabilities is $0.00

    Current liabilities

    $18.04M
    LIMN annual total current liabilities is $18.04 million

    Accounts payable

    $933.00K
    LIMN annual accounts payable is $933.00 thousand

    Debt

    Total debt

    $16.05M
    LIMN annual total debt is $16.05 million

    Total debt 1-year change

    -2.73%
    LIMN annual total debt is down -2.73% year-on-year

    Long term debt

    -
    LIMN annual long term debt value is unknown

    Short term debt

    $16.05M
    LIMN annual short term debt is $16.05 million

    Equity & Capital

    Shareholders equity

    $0.00
    LIMN annual stockholders equity is $0.00

    Book value

    -$15.79M
    LIMN annual book value is -$15.79 million

    Retained earnings

    -$25.12M
    LIMN annual retained earnings is -$25.12 million

    Working capital

    -$15.79M
    LIMN annual working capital is -$15.79 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.35M
    LIMN annual cash flow from operations is -$3.35 million

    Cash from operations 1-year change

    -284.93%
    LIMN annual cash flow from operations is down -284.93% year-on-year

    Cash from investing

    -$819.00K
    LIMN annual cash flow from investing activities is -$819.00 thousand

    Cash from investing 1-year change

    -100%
    LIMN annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    -$450.00K
    LIMN annual cash flow from financing activities is -$450.00 thousand

    Cash from financing 1-year change

    -107.61%
    LIMN annual cash flow from financing activities is down -107.61% year-on-year

    CAPEX

    CAPEX

    -
    LIMN annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    LIMN annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$3.35M
    LIMN annual free cash flow is -$3.35 million

    Free cash flow 1-year change

    -284.93%
    LIMN annual free cash flow is down -284.93% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    LIMN annual gross profit margin value is unknown

    Operating margin

    -
    LIMN annual operating profit margin value is unknown

    Net margin

    -
    LIMN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -222.30%
    LIMN annual return on assets is -222.30%

    ROE

    -
    LIMN annual return on equity value is unknown

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LIMN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LIMN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -208.35K
    LIMN price to book ratio is -208.35 thousand

    PB ratio Sector rank

    0%
    LIMN price to book ratio is higher than 0% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    LIMN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    LIMN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    LIMN enterprise value value is unknown

    Enterprise value Sector rank

    -
    LIMN enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    LIMN EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    LIMN EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.12
    LIMN annual current ratio is 0.12

    Quick ratio

    -
    LIMN annual quick ratio value is unknown

    Leverage

    Debt to equity

    -
    LIMN annual debt to equity ratio value is unknown

    Interest coverage ratio

    -27.48
    LIMN annual interest coverage ratio is -27.48

    Risk & Stability

    Piotroski F-Score

    -
    LIMN piotroski f-score value is unknown

    Altman Z-Score

    -
    LIMN altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with LIMN included

    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotechnology industry
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Liminatus Pharma Class A?
    • Does Liminatus Pharma Class A pay dividends?
    • What sector is Liminatus Pharma Class A in?
    • What industry is Liminatus Pharma Class A in?
    • What country is Liminatus Pharma Class A based in?
    • When did Liminatus Pharma Class A go public?
    • Is Liminatus Pharma Class A in the S&P 500?
    • Is Liminatus Pharma Class A in the NASDAQ 100?
    • Is Liminatus Pharma Class A in the Dow Jones?
    • When does Liminatus Pharma Class A report earnings?

    What is the ticker symbol for Liminatus Pharma Class A?

    The ticker symbol for Liminatus Pharma Class A is NASDAQ:LIMN

    Does Liminatus Pharma Class A pay dividends?

    No, Liminatus Pharma Class A does not pay dividends

    What sector is Liminatus Pharma Class A in?

    Liminatus Pharma Class A is in the Healthcare sector

    What industry is Liminatus Pharma Class A in?

    Liminatus Pharma Class A is in the Biotechnology industry

    What country is Liminatus Pharma Class A based in?

    Liminatus Pharma Class A is headquartered in United States

    When did Liminatus Pharma Class A go public?

    Liminatus Pharma Class A's initial public offering (IPO) was on May 1, 2025

    Is Liminatus Pharma Class A in the S&P 500?

    No, Liminatus Pharma Class A is not included in the S&P 500 index

    Is Liminatus Pharma Class A in the NASDAQ 100?

    No, Liminatus Pharma Class A is not included in the NASDAQ 100 index

    Is Liminatus Pharma Class A in the Dow Jones?

    No, Liminatus Pharma Class A is not included in the Dow Jones index

    When does Liminatus Pharma Class A report earnings?

    The date for Liminatus Pharma Class A's next earnings report has not been announced yet
    On this page